FR2837099B1 - Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives - Google Patents

Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives

Info

Publication number
FR2837099B1
FR2837099B1 FR0203059A FR0203059A FR2837099B1 FR 2837099 B1 FR2837099 B1 FR 2837099B1 FR 0203059 A FR0203059 A FR 0203059A FR 0203059 A FR0203059 A FR 0203059A FR 2837099 B1 FR2837099 B1 FR 2837099B1
Authority
FR
France
Prior art keywords
bio
composition
active substances
prolonged delivery
gelifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0203059A
Other languages
English (en)
Other versions
FR2837099A1 (fr
Inventor
Jean Christophe Leroux
Hoarau Anne Claude Couffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0203059A priority Critical patent/FR2837099B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to PCT/FR2003/000797 priority patent/WO2003075885A1/fr
Priority to MXPA04008906A priority patent/MXPA04008906A/es
Priority to AU2003227827A priority patent/AU2003227827B2/en
Priority to CA2478825A priority patent/CA2478825C/fr
Priority to CN03810055A priority patent/CN100584314C/zh
Priority to ES03725281.4T priority patent/ES2607980T3/es
Priority to US10/507,281 priority patent/US7691408B2/en
Priority to EP03725281.4A priority patent/EP1485066B1/fr
Priority to BRPI0308360A priority patent/BRPI0308360B8/pt
Priority to JP2003574161A priority patent/JP2005528352A/ja
Priority to KR1020047014388A priority patent/KR100906547B1/ko
Priority to NZ535270A priority patent/NZ535270A/en
Priority to HK05104957.8A priority patent/HK1071704B/xx
Publication of FR2837099A1 publication Critical patent/FR2837099A1/fr
Priority to IL164031A priority patent/IL164031A/en
Priority to ZA200407316A priority patent/ZA200407316B/en
Priority to NO20044310A priority patent/NO339426B1/no
Application granted granted Critical
Publication of FR2837099B1 publication Critical patent/FR2837099B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0203059A 2002-03-12 2002-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives Expired - Fee Related FR2837099B1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0203059A FR2837099B1 (fr) 2002-03-12 2002-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
NZ535270A NZ535270A (en) 2002-03-12 2003-03-12 Composition having gelling properties for the sustained delivery of bioactive substances
AU2003227827A AU2003227827B2 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
CA2478825A CA2478825C (fr) 2002-03-12 2003-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
CN03810055A CN100584314C (zh) 2002-03-12 2003-03-12 用于生物活性物质持续输送的具有凝胶化性能的组合物
ES03725281.4T ES2607980T3 (es) 2002-03-12 2003-03-12 Composición con propiedades gelificantes destinada al suministro prolongado de sustancias bioactivas
US10/507,281 US7691408B2 (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
EP03725281.4A EP1485066B1 (fr) 2002-03-12 2003-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
PCT/FR2003/000797 WO2003075885A1 (fr) 2002-03-12 2003-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
JP2003574161A JP2005528352A (ja) 2002-03-12 2003-03-12 生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物
KR1020047014388A KR100906547B1 (ko) 2002-03-12 2003-03-12 생활성 물질의 지속적 전달을 위한 겔화 특성을 갖는 조성물
MXPA04008906A MXPA04008906A (es) 2002-03-12 2003-03-12 Composicion que tiene propiedades gelificantes para el suministro prolongado de sustancias bioactivas.
HK05104957.8A HK1071704B (en) 2002-03-12 2003-03-12 Composition having gelling properties for the prolonged delivery of bioactive substances
BRPI0308360A BRPI0308360B8 (pt) 2002-03-12 2003-03-12 composição termossensível sob forma liquida compreendendo substância organogelificante, utilização de uma composição e processo de preparação de uma composição
IL164031A IL164031A (en) 2002-03-12 2004-09-12 Compositiion having gelling properaties for the prolonged delivery of bioactive substances
ZA200407316A ZA200407316B (en) 2002-03-12 2004-09-13 Composition having gelling properties for the prolonged delivery of bioactive substances.
NO20044310A NO339426B1 (no) 2002-03-12 2004-10-12 Sammensetning som har gelerende egenskaper til forsinket levering av bioaktive stoffer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203059A FR2837099B1 (fr) 2002-03-12 2002-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives

Publications (2)

Publication Number Publication Date
FR2837099A1 FR2837099A1 (fr) 2003-09-19
FR2837099B1 true FR2837099B1 (fr) 2005-03-18

Family

ID=27772051

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203059A Expired - Fee Related FR2837099B1 (fr) 2002-03-12 2002-03-12 Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives

Country Status (3)

Country Link
ES (1) ES2607980T3 (fr)
FR (1) FR2837099B1 (fr)
ZA (1) ZA200407316B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969087A (en) * 1974-08-07 1976-07-13 Ajinomoto Co., Ltd. Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
FR2794998B1 (fr) * 1999-06-21 2001-07-27 Oreal Organogels et leurs utilisations notamment cosmetiques

Also Published As

Publication number Publication date
ES2607980T3 (es) 2017-04-05
ZA200407316B (en) 2006-02-22
FR2837099A1 (fr) 2003-09-19

Similar Documents

Publication Publication Date Title
DK1545662T3 (da) Lægemiddelindgivelsessystem
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
NO20050036L (no) Sure insulinpreparater med forbedret stabilitet
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
EP1513825A4 (fr) Medicament anti-tuberculeux: compositions et methodes
AU2003291103A8 (en) Pharmaceutical composition
IS7571A (is) Ný lífeðlisfræðilega virk efni
DK1587478T3 (da) Farmaceutisk sammensætning
GB2391809B (en) Pharmaceutical composition comprising honey
AU2003250372A8 (en) Pharmaceutical composition
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
ATE546141T1 (de) Pharmazeutisches injektionspräparat
DK1474152T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende ivabradin
DK1467750T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende perindopril
ZA200506750B (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluroanilino) phenylacetic acid
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
GB0317877D0 (en) Pharmaceutical combinations and formulations with improved stability
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
GB0327006D0 (en) Drug compositon and therapeutics
HU0200337D0 (en) Stabilised pharmaceutical composition
GB0406014D0 (en) Pharmaceutical composition and use
GB0327814D0 (en) Aerosolisable composition and delivery system
AU2003232176A8 (en) Protein c variants with altered properties
GB0217703D0 (en) Pharmaceutical composition
ATE444305T1 (de) Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungen

Legal Events

Date Code Title Description
TQ Partial transmission of property
GC Lien (pledge) constituted

Effective date: 20140519

PLFP Fee payment

Year of fee payment: 14

GC Lien (pledge) constituted

Effective date: 20160120

PLFP Fee payment

Year of fee payment: 15

RG Lien (pledge) cancelled

Effective date: 20160226

PLFP Fee payment

Year of fee payment: 16

RG Lien (pledge) cancelled

Effective date: 20170418

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20211105